Is Otsuka public or private?
Otsuka Holdings Co., Ltd. functions as a publicly traded corporate entity rather than a privately held enterprise. Its equity shares are freely bought and sold by public investors on major stock exchanges, and its financial records, executive compensation details, and strategic corporate updates are openly disclosed to regulatory authorities and shareholders in accordance with international public market laws.
Related FAQs
Otsuka is a significant multi-industry conglomerate, and its market capitalization, which serves as the most accurate measure of its public worth, stands at approximately ₹608.22 billion as of July 2026 [1.5.1].
The share price of Otsuka Holdings Co., Ltd. (traded on the Tokyo Stock Exchange under the ticker 4578) is approximately 11,500.00 JPY.
Otsuka Holdings Co., Ltd. trades on the Tokyo Stock Exchange under the primary stock code 4578.
Otsuka Pharmaceutical is a research-driven healthcare enterprise that develops and manufactures a wide-ranging portfolio of pharmaceutical drugs, prescription medications, and specialized nutritional products.
Otsuka Pharmaceutical maintains a robust global neuroscience product portfolio that includes several cornerstone medications prescribed for psychiatric and neurological conditions.